Alkermes, Inc. (ALKS) Lobbying Data
ALKS lobbying summary
Alkermes, Inc (ALKS) has reported $33.7M in federal lobbying spending across 264 Senate LDA filings since 2020. Its most frequent lobbying issues are Health Issues, Medicare/Medicaid, Alcohol, Pharmacy. Lobbying firms used include Todd Strategy Group, Splitoak Strategies LLC, Penn Avenue Partners.
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2026 | $4.7M |
| 2025 | $6.4M |
| 2024 | $3.8M |
| 2023 | $5.0M |
| 2022 | $4.3M |
| 2021 | $4.5M |
See insider trading for ALKS or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.